Latest Earnings Results: Q2 '26
Estimated EPS
-$0.47
Reported EPS
-$0.51
Surprise
-8.24%
Estimated Rev
$27.28M
Reported Rev
$28.1M
Surprise
+3.01%
• Reported GAAP EPS of -$0.51 down -34.21% YoY • Reported revenue of $28.1M up 32.54% YoY
Bullish Takeaway
CeriBell demonstrated strong growth with a 33% increase in total revenue for the quarter and expanded its market footprint to over 700 hospitals, supported by new FDA product clearances.
Bearish Takeaway
CeriBell continues to incur operating losses and carries a significant accumulated deficit, while facing structural risks from international manufacturing reliance and the supplemental, non-essential nature of its products.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.51 | -- | -- | N/A |
Q2 '26 | -$0.47 | -$0.51 | -8.24% | MISSED |
Q1 '26 | -$0.39 | -$0.52 | -33.07% | MISSED |
Q4 '25 | -$0.41 | -$0.36 | 12.65% | BEAT |
Q3 '25 | -$0.41 | -$0.37 | 10.68% | BEAT |